Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20809380 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: Rilpivirine;   Drug: Placebo

Indicates status has not been verified in more than two years